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cense.Abstract In this study reaction of 1-(biphenyl-4-carbonyl)benzoic acid (1) with hydrazine hydrate,
phenyl hydrazine, acetyl hydrazine and benzoyl hydrazine in boiling dry benzene gave the corre-
sponding 4-biphenyl-4-yl-(2H)-phthalazin-1-one (2a–d), respectively. The structure of 2c was estab-
lished via its reaction with 2-chlorobenzaldehyde, 2-nitrobenzaldehyde in ethanol to give the
chalcones 3a,b, respectively. On the other hand, the cyclocondensation of the acid 1 with semicarb-
azide and thiosemicarbazide in sodium acetate gave phthalazinone amide/thioamide 4a,b, respec-
tively. The reaction of 1 with hydroxyl amine hydrochloride in different media was also studied,
to give the oxime derivative 5, which was readily converted to benzooxazin-1-one derivative 6 by
boiling in acetic anhydride. Compound 6 was also obtained, when the acid 1 was reacted with
hydroxyl amine hydrochloride in boiling pyridine. In addition, the phthalazinone derivative 2a
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60 S.A. Abubshait et al.to give Mannich bases 7a–d, respectively. The structural assignment of the new compounds was
based on analytical and spectral data. And some of the new products showed antimicrobial activity.
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A number of phthalazine and phthalazinone derivatives occur
very widely in nature and are essential to life. Phthalazine
and phthalazinone like other members of isomeric diazine ser-
ies have found wide applications and pharmacological proper-
ties such as anticovulsants (Vaughan, 1948), antiasthmatic
effects, anti-inﬂammatory (Yamaguchi et al., 1993; Der May
et al., 2001; Olmo et al., 2001 and Bedoya et al., 2006), thera-
peutic agents (Porter et al., 1979), anti-ulcers (Engel and Schef-
fer, 1989) and inhibitors of the enzyme Alfosfodaestez
(Watanabe et al., 1998). Also phthalazine and phthalazinone
derivatives represent key intermediate in the synthesis of vari-
ous compound with highly interesting pharmacological proper-
ties such as anti-heart disease (Moro et al., 1991), blood platelet
aggregation inhibitors, cardiovascular antihypertensive agents
(Sugimoto et al., 1984; Brizzi et al., 1986; Eguchi and Ishikawa,
1991; Hider, 1995; Jian and Cheng, 1999; Coelho et al., 2004;
Lu et al., 2004 and Monsieurs et al., 2007) an aldose reductive
inhibitor for the treatment of diabetes complications (Brizzi
et al., 1986 and Del-Olmo et al., 2006). Derivatives of phthal-
azine and phthalazinone are well known as antimicrobial (Said
et al., 1991), anti fungal (El-Tammaty et al., 1996), anti para-
sitic (Wang et al., 2007) and also have proven useful biological
sensitivity to antibiotics (Morinako et al., 1986 and Yoshimura,
1994). They have found application in clinical medicine due to
their pronounced antipyretic, analgesic and tuberculastatic
activity (Jian and Cheng, 1999) also used as anticancer agents
and antitumor activity (Yamaguchi et al., 1993).
In this work, we aimed to prepare a new series of compounds
through the nucleophilic addition to 2-(biphenyl-4-car-
bonyl)benzoic acid followed by cyclocondensation of the result-
ingadducts.Therefore,weare interestedon the formationof ring
systemwith biological activities which prompted us to screening
some of these new compounds for antimicrobial activity.
2. Experimental
2.1. General
All melting points were determined on Gallen Kamp and
uncorrected. IR spectra were measured with a Pye-Unicam
spectrophotometer type 1200, using potassium bromide disk;
results are given in cm1. 1H NMR and 13C NMR spectra were
recorded at 200 and 90.56 MHz, respectively, and in the sol-
vent CDCl3 (or DMSO-d6). The chemical shifts are reported
in parts per million (ppm) downﬁeld from internal tetrameth-
ylsilane (TMS) and coupling constants (J) are given in Hz.
Electron impact MS spectra were obtained on a Mat-711 spec-
trometer inlet temperature Ca, 200 C instrument at 70 eV.
Elemental microanalysis was done on a Parkin–Elmer 240.
2.2. 2-(Biphenylcarbonyl)benzoic acid 1
It was prepared following the literature procedure (Sayed et al.,
1981; Sayed et al., 2002 and Abubshait, 2007). White powder,m.p. 210 C (from benzene), yield 90.00%; IR
(cm1): 3410–3200 (OH), 3055–3031 (CH-Ar), 1770 (C‚O,
acid), 1693 (C‚O, ketone), 1600 (C‚C); 1H NMR(DMSO-
d3): 7.41 (1H, dd, J(c0,e0) = 4, J(b0,f0) = 2.2, H-d
0), 7.45 (2H, dd,
J(b0,f0) = 8, J(d0) = 4, H-c
0,e0), 7.49 (2H, dd, J(c0,e0) = 8,
J(d0) = 2.2, H-b
0,f0), 7.53 (1H, dd, J(6,8) = 6, J(5) = 2.2, H-7),
7.65 (1H, dd, J(5,7) = 6, J(8) = 2.2, H-6), 7.71 (2H, d,
J(b,f) = 10, H-c,e), 7.76 (2H, d, J(c,e) = 10, H-b,f), 7.81 (1H,
dd, J(7) = 6, J(6) = 2.2, H-8), 8.08 (1H, dd, J(6) = 6,
J(7) = 2.2, H-5), 13.27 (1H, br, OH);
13C NMR(DMSO-d6):
196.09 (C‚O), 166.95 (C‚O), 127.00,127.60, 127.90, 128.20,
129.20, 130.80, 131.80, 132.30, 133.6, 140.50, 144.5 (C-Ar);
MS: m/z(%) 302.09[M+]:C20H14O3 (9.9%), 181:C13H9O-
(100%); calcd. for C20H14O3: C,79.60; H, 4.67%; found: C,
79.09; H, 4.61.
2.3. General procedure for synthesis of 2a-d
2.3.1. Method A: for synthesis of 2a–d
A mixture of acid 1 (3.02 g, 10 mmol), with hydrazines (hydra-
zine hydrate, phenylhydrazine, acetylhydrazide and benzoyl
hydrazide) (10 mmol) in dry benzene (50 mL) was prepared
and reﬂuxed for 8 h. After concentration and cooling, the sol-
ids that separated were recrystallized from the proper solvent
to give 2a–d, respectively.2.3.1.1. 4-(Biphenyl-4-yl)-(2H)-phthalazin-1-one (2a). White
needles, m.p. 260 C (from ethanol), yield 96.56%; IR
(cm1): 3421(NH), 3030–2928(CH-aromatic and aliphatic),
1658 (C‚O), 1608 (C‚N), 1550 (C‚C); 1H NMR(DMSO-
d6): 7.41 (1H, dd, J(c0,e0) = 4, J(b0,f0) = 2, H-d
0), 7.47 (1H, dd,
J(b0,f0) = 8, J(d0) = 4, H-c
0,e0), 7.53 (2H, dd, J(c0,e0) = 8,
J(d0) = 2, H-b
0,f0), 7.73 (2H, dd, J(6,8) = 8, J(5) = 1.2, H-7),
7.76 (1H, dd, J(5,7) = 8, J(8) = 4.6, H-6), 7.87 (2H, d,
J(b,f) = 10, H-c,e), 7.95 (2H, d, J(c,e) = 10, H-b,f), 8.35 (1H,
dd, J(6) = 8, J(7) = 1.2, H-5), 8.39 (1H, dd, J(7) = 8,
J(6) = 4.6, H-8), 12.87 (1H, s, ANH); MS: m/z(%) 298 [M
+]:
C20H14N2O (100%); calcd. for C20H14N2O:C, 80.52; H, 4.73;
N, 9.39%; found: C, 80.61; H,4.89; N, 9.16%.
2.3.1.2. 4-(Biphenyl-4-yl)-2-phenyl-(2H)-phthalazin-1-one
(2b). Dark brown powder, m.p. 130 C (from benzene), yield
53.21%; IR (cm1): 3045–3031(CH-aromatic and aliphatic),
1674 (C‚O), 1593 (C‚N), 1535 (C‚C); 1H NMR(DMSO-
d6): 7.39 (1H, dd, J(30,50) ‚4, J(20,60) = 0.2, H-40), 7.42 (1H, dd,
J(c0,e0) = 4, J(b0,f0) = 2, H-d
0), 7.46 (1H, dd, J(b0,f0) = 8,
J(d0) = 4, H-c
0,e0), 7.54 (2H, dd, J(40) = 4, J(20,60) = 3,H-30,50),
7.55 (2H, dd, J(c0,e0) = 8, J(d0) = 2, H-b
0,f0), 7.73 (2H, dd,
J(6,8) = 8, J(5) = 1.2, H-7), 7.83 (1H, dd, J(5,7) = 8,
J(8) = 4.6, H-6), 7.86 (2H, dd, J(30,50) = 3, J(40) = 0.2, H-2
0,60),
7.87 (2H, d, J(b,f) = 10, H-c,e), 7.99 (2H, d, J(c,e) = 10, H-
b,f), 8.46 (1H, dd, J(6) = 8, J(7) = 1.2, H-5), 8.51 (1H, dd,
J(7) = 8, J(6) = 4.6, H-8); MS: m/z(%) 374[M
+]: C26H18N2O
(100%); calcd. for C26H18N2O: C, 83.40; H, 4.85; N, 7.48%;
found: C, 83.42; H, 4.81; N, 7.49%.
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(2c). Yellow powder, m.p. 175 C (from benzene), yield
64.47%; IR (cm1): 3030–2884(CH-aromatic and aliphatic),
1669 (C‚O), 1599 (C‚N), 1520 (C‚C); 1H NMR(DMSO-
d6): 2.28 (3H, s, CH3), 7.38 (1H, dd, J(c0,e0) = 4, J(b0,f0) = 2,
H-d0), 7.47 (1H, dd, J(b0,f0) = 8, J(d0) = 4, H-c0,e0), 7.53 (2H,
dd, J(c0,e0) = 8, J(d0) = 2, H-b
0,f0), 7.78 (2H, dd, J(6,8) = 8,
J(5) = 1.2, H-7), 7.79 (1H, dd, J(5,7) = 8, J(8) = 4.6, H-6),
7.88 (2H, d, J(b,f) = 10, H-c,e), 7.99 (2H, d, J(c,e) = 10, H-
b,f), 8.35 (1H, dd, J(6) = 8, J(7) = 1.2, H-5), 8.37 (1H, dd,
J(7) = 8, J(6) = 4.6, H-8); MS: m/z(%) 340 [M
+]:
C22H16N2O2 (22.3%), 297: C20H13N2O (100%); calcd. for
C22H16N2O2: C, 77.63; H, 4.74; N, 8.23%; found: C, 77.65;
H, 4.71; N, 8.24%.
2.3.1.4. 2-Benzoyl-4-(biphenyl-4-yl)-(2H)-phthalazin-1-one
(2d). White powder, m.p. 200 C (from benzene), yield
49.34%; IR (cm1): 3052–3014(CH-aromatic and aliphatic),
1692, 1670 (C‚O), 1632 (C‚N), 1575 (C‚C); 1H
NMR(DMSO-d6): 7.38 (1H, s, H-4
0), 7.48 (2H, s, H-30,50),
7.49 (1H, dd, J(c0,e0) = 4, J(b0,f0) = 2, H-d
0), 7.52 (1H, dd,
J(b0,f0) = 8, J(d0) = 4, H-c
0,e0), 7.54 (2H, dd, J(c0,e0) = 8,
J(d0) = 2, H-b
0,f0), 7.74 (2H, s, H-20,60), 7.79 (2H, dd, J(6,8) =
8, J(5) = 1.2, H-7), 7.84 (1H, dd, J(5,7) = 8, J(8) = 4.6, H-6),
7.91 (2H, d, J(b,f) = 10, H-c,e), 8.04 (2H, d, J(c,e) = 10, H-
b,f), 8.46 (1H, dd, J(6) = 8, J(7) = 1.2, H-5), 8.56 (1H, dd,
J(7) = 8, J(6) = 4.6, H-8); MS: m/z(%) 402[M
+]:
C27H18N2O2 (12.4%), 105: C7H5O (100%); calcd. for
C27H18N2O2: C, 80.58; H, 4.51; N, 6.96; found: C, 80.56; H,
4.48; N, 6.93%.
2.3.2. Method B: for synthesis of 2c
A solution of 2a (2.98 g, 10 mmol) in a mixture of acetic acid
and acetic anhydride (1:1, 20 mL) was prepared and reﬂuxed
for 10 h. After concentration and cooling, the solid that ob-
tained was recrystallized from ethanol to give 2c.
2.3.3. Method C: for synthesis of 2d
A solution of 2a (2.98 g, 10 mmol) and benzoyl chloride
(1.41 g, 10 mmol) in pyridine (5 mL) was reﬂuxed for 6 h. After
cooling, the reaction mixture was poured onto ice and dilute
hydrochloric acid mixture then the solid that separated was
collected, washed well with water and recrystallized from ben-
zene 2d.
2.4. General procedure for synthesis of 3a,b
A mixture of 2c (3.40 g, 10 mmol), 2-chlorobenzaldehyde and/
or 2-nitrobenzaldehyde (10 mmol) in ethanol (40 mL) and
NaOH (10 mL, 10%) was allowed to stand at room tempera-
ture over night, then diluted with water and acidiﬁed with di-
lute hydrochloric acid. The solids that separated were ﬁltered
and recrystallized from benzene to give compounds 3a,b,
respectively.
2.4.1. 4-(Biphenyl-4-yl)-2-[3-(20-chlorophenyl)acryloyl]-
(2H)-phthalazin-1-one (3a)
White powder, m.p. 190 C (form benzene), 53.66% yield; IR
(cm1): 3053–2890(CH-aromatic and aliphatic), 1667 (C‚O),
1599 (C‚N), 1530 (C‚C), 765(C-Cl); 1H NMR(DMSO-d6):
6.85, 7.90 (2H, d, J = 14, ACHA), 7.26 (1H, dd, J(30,50) = 8,J(60) = 4, H-4
0), 7.28 (1H, dd, J(40,60) = 8, J(30) = 4, H-50), 7.30
(1H, ddd, J(50) = 8, J(40) = 4, J(30) = 1.2, H-6
0), 7.39 (1H, dd,
J(c0,e0) = 8, J(b0,f0) = 2, H-d
0), 7.45 (1H, ddd, J(40) = 8,
J(50) = 4, J(60) = 1.2, H-3
0), 7.52 (2H, dd, J(b0,f0) = 8, J(d0) = 2,
H-c0,e0), 7.54 (2H, dd, J(c0,e0) = 8, J(d0) = 2, H-b0,f0), 7.77 (1H,
dd, J(6,8) = 8, J(5) = 4, H-7), 7.84 (1H, dd, J(5,7) = 8,
J(8) = 2, H-6), 7.96 (2H, d, J(b,f) = 7.2, H-c,e), 8.05 (2H, d,
J(c,e) = 7.2, H-b,f), 8.35 (1H, dd, J(6) = 8, J(7) = 4, H-5), 8.39
(1H, dd, J(7) = 8, J(6) = 2, H-8); MS: m/z(%) 461[M
+]:
C29H19ClN2O2 (100%); calcd. for C29H19ClN2O2: C, 75.24;
H, 4.41; N, 6.05%; found: C, 75.36; H, 4.34; N, 6.00%.
2.4.2. 4-(Biphenyl-4-yl)-2-[3-(20-nitrophenyl)acryloyl]-(2H)-
phthalazin-1-one (3b)
Yellow powder, m.p. 205 C (from benzene), 47.62% yield; IR
(cm1): 3029–2893(CH-aromatic and aliphatic), 1657 (C‚O),
1593 (C‚N), 1495, 1230(NO2);
1H NMR(DMSO-d6):
7.20,8.20 (2H, d, J = 15, ACH), 7.41 (1H, dd, J(c0,e0) = 8,
J(b0,f0) = 2, H-d
0), 7.52 (2H, dd, J(b0,f0) = 8, J(d0) = 2, H-c0,e0),
7.55 (2H, dd, J(c0,e0) = 8, J(d0) = 2, H-b
0, f0), 7.79 (1H, dd,
J(6,8) = 8, J(5) = 4, H-7), 7.84 (1H, dd, J(5,7) = 8, J(8) = 2,
H-6), 7.86 (1H, dd, J(40,60) = 8, J(30) = 4, H-5
0), 7.91 (1H, dd,
J(30,50) = 8, J(60) = 4, H-4
0), 7.94 (2H, d, J(b,f) = 7.2, H-c,e),
8.04 (2H, d, J(c,e) = 7.2, H-b,f), 8.06 (1H, ddd, J(50) = 8,
J(40) = 4, J(30) = 1.2, H-6
0), 8.21 (1H, ddd, J(40) = 8, J(50) = 4,
J(60) = 1.2, H-3
0), 8.35 (1H, dd, J(6) = 8, J(7) = 4, H-5), 8.39
(1H, dd, J(7) = 8, J(6) = 2, H-8); MS: m/z (%) 473[M
+]:
C29H19N3O4(100%); calcd. for C29H19N3O4: C, 73.56; H,
4.04; N, 8.87%; found: C, 73.57; H, 4.02; N, 8.88%.
2.5. General procedure for synthesis of 4a,b
A mixture of crystalline sodium acetate (0.082 g, 1 mmol) and
semicabazide and/or thiosemicarbazide (10 mmol) in water
(2 ml) was added with stirring to a solution of 1 (3.02 g,
10 mmol) in ethanol (50 mL, 95%), then reﬂuxed for 6 h. After
concentration and cooling the solids that separated were
recrystallized from benzene to give 4a,b, respectively.
2.5.1. 4-(biphenyl-4-yl)-1-oxo-(1H)-phthalazin-2-carboxamide
(4a)
White solid, m.p. 176 C (from benzene); 43.48% yield; IR
(cm1): 3432, 3110(NH2), 3020–2996(CH-aromatic), 1693, 1674
(C‚O), 1608 (C‚N), 1573 (C‚C); 1H NMR(DMSO-d6):
7.41 (1H, dd, J(c0,e0)= 8, J(b0,f0)= 2, H-d
0), 7.52 (2H, dd,
J(b0,f0)= 8, J(d0)= 2, H-c
0,e0), 7.54 (2H, dd, J(c0,e0)= 8, J(d0)= 2,
H-b0,f0), 7.79 (1H, dd, J(6,8)= 8, J(5) = 4, H-7), 7.84 (1H, dd,
J(5,7)= 8, J(8)= 2, H-6), 7.91 (2H, d, J(b,f) = 7.2, H-c,e), 8.04
(2H, d, J(c,e) = 7.2, H-b,f), 8.35 (1H, dd, J(6)= 8, J(7)= 4, H-
5), 8.38 (1H, dd, J(7)= 8, J(6)= 2, H-8), 10.00 (2H, br,
ANH2); MS: m/z (%) 431[M
+]: C21H15N3O2(100%), calcd.
for C21H15N3O2: C, 73.89; H, 4.43; O, 12.31; found: C, 73.86;
H, 4.39; N,12.35%.
2.5.2. 4-(biphenyl-4-yl)-1-oxo-(1H)-phthalazin-2-
carbothioamide (4b)
White solid, m.p. 150 C (from benzene), 25.42% yield; IR
(cm1): 3371,3105(NH2), 3029–2989(CH-aromatic); 1643
(C‚O), 1616 (C‚N), 1531 (C‚C), 1284 (C‚S); 1H NMR-
(DMSO-d6): 7.43 (1H, dd, J(c0,e0) = 8, J(b0,f0) = 2, H-d
0), 7.51
(2H, dd, J(b0,f0) = 8, J(d0) = 2, H-c
0,e0), 7.55 (2H, dd, J(c0,e0) = 8,
62 S.A. Abubshait et al.J(d0) = 2, H-b
0,f0), 7.78 (1H, dd, J(6,8) = 8, J(5) = 4, H-7), 7.84
(1H, dd, J(5,7) = 8, J(8) = 2, H-6), 7.92 (2H, d, J(b,f) = 7.2,
H-c,e), 8.01 (2H, d, J(c,e) = 7.2, H-b,f), 8.35 (1H, dd, J(6) = 8,
J(7) = 4, H-5), 8.38 (1H, dd, J(7) = 8, J(6) = 2, H-8), 10.00
(2H, br, ANH2); MS: m/z (%) 357 [M
+]: C21H15N3OS
(17.3%), 284:C20H14NO(100%); calcd. for C21H15N3OS: C,
70.57; H, 4.23; N, 11.78; S, 8.97%; found: C, 70.51; H, 4.19;
N, 11.69; S, 8.93%.
2.6. Synthesis of 4-(biphenyl-4-yl)-hydroxyimino methyl)
benzoic acid (5)
A mixture of acid 1 (3.02 g, 10 mmol), hydroxylamine hydro-
chloride (0.69 g, 10 mmol) and (sodium hydroxide 0.3 g in
water 2 mL) in ethanol (50 mL) was prepared and reﬂuxed
for 6 h. The solid that separated was ﬁltered and recrystallized
from benzene to give 5 as yellow solid, m.p. 310 C (from ben-
zene), yield 50.0%; IR (cm-1): 3430(OH), 3060–3029(CH-aro-
matic), 1727 (C‚O, acid), 1667 (C‚N, oxime), 1525
(C‚C); 1H NMR(DMSO-d6): 7.40 (1H, dd, J(c0,e0) = 4,
J(b0,f0) = 2.2, H-d
0), 7.46 (2H, dd, J(b0,f0) = 8, J(d0) = 4, H-c0,e0),
7.50 (2H, dd, J(c0,e0) = 8, J(d0) = 2.2, H-b
0,f0), 7.53 (1H, dd,
J(6,8) = 6, J(5) = 2.2, H-7), 7.65 (1H, dd, J(5,7) = 6,
J(8) = 2.2, H-6), 7.71 (2H, d, J(b,f) = 10, H-c,e), 7.75 (2H, d,
J(c,e) = 10, H-b,f), 7.82 (1H, dd, J(7) = 6, J(6) = 2.2, H-8),
8.37 (1H, dd, J(6) = 6, J(7) = 2.2, H-5), 11.00(2H, br, AOH),
13.27 (1H, br, OH); MS: m/z (%): 317[M+]: C20H15NO3
(100%); calcd. for C20H15NO3: C, 75.70; H, 4.76; N, 4.41%;
found: C, 75.73; H, 4.77; N, 4.44%.
2.7. General procedure for synthesis of 6
2.7.1. Method A: for synthesis of 6
Amixture of acid 1 (3.02 g, 10 mmol) andhydroxylamine hydro-
chloride (0.69 g, 10 mmol) in pyridine (30 mL)was prepared and
reﬂuxed for 10 h. Then poured the mixture in hydrochloric acid
(30 mL) andmashed ice (0.03 g). The solid that separatedwas ﬁl-
tered and recrystallized from ethanol to give 6 as a light brown
compounds; m.p. 170 C (from ethanol), 89.8% yield; IR
(cm1): 3065–3030(CH-aromatic), 1632 (C‚N), 1670 (C‚O),
1532 (C‚C); 1H NMR(DMSO-d6): 7.47 (1H, dd, J(c0,e0) = 4,
J(b0,f0) = 2.2, H-d
0), 7.52 (2H, dd, J(b0,f0) = 8, J(d0) = 4, H-c0,e0),
7.58 (2H, dd, J(c0,e0) = 8, J(d0) = 2.2, H-b
0,f0), 7.62 (1H, dd,
J(6,8) = 6, J(5) = 2.2, H-7), 7.75 (1H, dd, J(5,7) = 6, J(8) = 2.2,
H-6), 7.79 (2H, d, J(b,f) = 10, H-c,e), 7.92 (2H, d, J(c,e) = 10,
H-b,f), 8.06 (1H, dd, J(7) = 6, J(6) = 2.2, H-8), 8.42 (1H, dd,
J(6) = 6, J(7) = 2.2, H-5); MS: m/z(%) 299[M
+]: C20H13NO2
(100%); calcd. for C20H13NO2: C, 80.25; H, 4.38; N,4.68%;
found: C, 80.23; H, 4.35; N, 4.63%.
2.7.2. Method B: for synthesis of 6
A solution of 5 (3.17 g, 10 mmol) in acetic anhydride (20 mL)
was reﬂuxed onwater bath for 4 h, after concentration and cool-
ing, the solid was obtained and recrystallized from ethanol to
give 6.
2.8. General procedure for synthesis of 7a–d
A mixture of 2a (2.98 g, 10 mmol), phthalimide, morpholine,
o-cresole and/or b-naphthol (20 mmol) in formaldehyde
(2 mL) was added to mixture of ethanol: acetone(30 mL, 1:1)
in hydrochloric acid (2 mL) the resulting reaction mixturewas reﬂuxed for 16 h. The solid that separated was ﬁltered
and recrystallized from benzene to give 7a–d, respectively.
2.8.1. 2-[4-(biphenyl-4-yl)-1-oxo-(1H)-phthalazin-2-yl-
methyl]-isoindoline-1,3-dione (7a)
White powder, m.p. 190 C (from benzene); 33.16% yield; IR
(cm1): 3061–2920(CH-aromatic and aliphatic); 1663
(C‚O), 1602 (C‚N); 1H NMR(CDCl3): 5.54(2H, s, ACH2),
7.41 (1H, dd, J(c0,e0) = 8, J(b0,f0) = 4H-d
0), 7.49 (1H, d,
J(b0,d0,f0) = 8, H-c
0,e0), 7.52 (2H, dd, J(c0,e0) = 8, J(d0) = 4, H-
b0,f0), 7.74 (2H, dd, J(6,8) = 8, J(5) = 1.2, H-7), 7.78 (1H, dd,
J(5,7) = 8, J(8) = 4.6, H-6), 7.87 (2H, d, J(50,60) = 8, H-4
0,70),
7.88 (2H, d, J(b,f) = 10, H-c,e), 7.94 (2H, d, J(c,e) = 10, H-
b,f), 7.95 (2H, d, J(40,70) = 8, H-5
0,60), 8.34 (1H, dd, J(6) = 8,
J(7) = 1.2, H-5), 8.38 (1H, dd, J(7) = 8, J(6) = 4.6, H-8); MS:
m/z (%) 457[M+]: C29H19N3O3 (46.8%), 297: C20H13N2O
(100%); calcd. for C29H19N3O3: C, 76.14; H, 4.91; N, 9.19%,
found: C, 76.06; H, 4.94; N, 9.21%.
2.8.2. 4-(biphenyl-4-yl)-2-morpholin-4-yl-methyl-(1H)-
phthalazin-1-one (7b)
White powder, m.p. 165 C (from benzene); 27.42% yield; IR
(cm-1): 3081–2849(CH-aromatic and aliphatic), 1652 (C‚O),
1589 (C‚N); 1H NMR(CDCl3): 2.45(4H, m, CH2–N),
3.72(4H, m, CH2–O), 5.01(2H, s, ACH2), 7.41 (1H, dd,,
J(c0,e0) = 8, J(b0,f0) = 4, H-d
0), 7.46 (1H, d, J(b0,d0,f0) = 8, H-c0,e0),
7.57 (2H, dd, J(c0,e0) = 8, J(d0) = 4, H-b
0,f0), 7.72 (2H, dd,
J(6,8) = 8, J(5) = 1.2, H-7), 7.81 (1H, dd, J(5,7) = 8,
J(8) = 4.6, H-6), 7.87 (2H, d, J(b,f) = 10, H-c,e), 7.95 (2H, d,
J(c,e) = 10, H-b,f), 8.39 (1H, dd, J(6) = 8, J(7) = 1.2, H-5),
8.51 (1H, dd, J(7) = 8, J(6) = 4.6, H-8); MS: m/z (%):
457[M+]: C25H23N3O2 (46.8%); calcd. for C25H23N3O2: C,
75.54; H, 5.83; N, 10.57%; found: C, 75.60; H, 5.90; N, 10.58%.
2.8.3. 4-(biphenyl-4-yl)-2-(4-hydroxy-3-methylbenzyl)-(2H)-
phthalazin-1-one (7c)
White powder, m.p. 140 C (from benzene); 30.51% yield; IR
(cm1): 3385(OH); 3083–2851(CH-aromatic and aliphatic),
1661 (C‚O), 1588 (C‚N); 1H NMR(CDCl3): 2.15(3H, s,
CH3-Ar), 5.35 (1H, br, AOH), 5.92 (2H, s, ACH2-Ar), 6.81
(1H, d, J(60) = 8, H-5
0), 6.90 (1H, s, H-20), 7.05 (1H, d,
J(50) = 8, H-6
0), 7.42 (1H, dd, J(c0,e0) = 8, J(b0,f0) = 4, H-d0),
7.47 (1H, d, J(b0,d,f0) = 8, H-c
0,e0), 7.52 (2H, dd, J(c0,e0) = 8,
J(d0) = 4, H-b
0,f0), 7.78 (2H, dd, J(6,8) = 8, J(5) = 1.2, H-7),
7.80 (1H, dd, J(5,7) = 8,J(8) = 4.6, H-6), 7.89 (2H, d,
J(b,f) = 10, H-c,e), 7.92 (2H, d, J(c,e) = 10, H-b,f), 8.35 (1H,
dd, J(6) = 8, J(7) = 1.2, H-5), 8.49 (1H, dd, J(7) = 8,
J(6) = 4.6 H-8); MS: m/z (%): 418[M
+]: C28H22N2O2
(100%(; calcd. for C28H22N2O2: C, 80.36; H, 5.30; N, 6.69%;
found: C,80.30; H,5.26; N,6.65%.
2.8.4. 4-(biphenyl-4-yl)-2-[(2-hydroxy-naphthalen-1-
yl)methyl]-(2H)-phthalazin-1-one (7d)
Light yellow powder, m.p. 225 C (from benzene); 29.05%
yield, IR (cm1): 3332(OH), 3022–2998(CH-aromatic and
alphatic), 1668 (C‚O), 1587 (C‚N); 1H NMR(CDCl3):
5.35(1H, br, AOH), 6.10(2H, s, ACH2), 6.87 (1H, d,
J(40) = 8, H-3
0), 7.41 (1H, dd, J(50,70) = 8, J(80) = 2, H-60),
7.44 (1H, dd, J(c0,e0) = 8, J(b0,f0) = 4, H-d
0), 7.52 (1H, d,
J(b0,d0,f0) = 8, H-c
0,e0), 7.55 (1H, dd, J(60,80) = 8, J(50) = 2, H-70),
7.56 (2H, dd, J(c0,e0) = 8, J(d0) = 4, H-b
0,f0), 7.69 (1H, d,
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0), 7.79 (2H, dd, J(6,8)= 8, J(5) = 1.2, H-7), 7.81
(1H, dd, J(5,7)= 8, J(8) = 4.6, H-6), 7.87 (2H, d, J(b,f) = 10,
H-c,e), 7.95 (2H, d, J(c,e) = 10, H-b,f), 8.00 (2H, m, H-8
0,50),
8.35 (1H, dd, J(6) = 8, J(7) = 1.2, H-5), 8.38 (1H, dd, J(7) = 8,
J(6)= 4.6, H-8); MS: m/z (%): 454[M
+]: C31H22N2O2
(100%(; calcd. for C31H22N2O2: C, 81.92; H, 4.88; N, 6.16%;
found: C, 81.96; H, 4.84; N, 6.11%.
3. Results and discussion
In the present study phthalic anhydride was reacted with
biphenyl compound under Friedel–Craft0s condition to give
2-(biphenyl-4-carbonyl)benzoic acid (1) (Sayed et al.,1981;
Sayed et al., 2002; Abubshait, 2007; Joshi and Khosla, 2008).
The structure of 1 was derived for its infrared spectrum which
showed m OH acid at 3410–3200 cm1, m CH-Ar at 3055–
3031 cm1, m C‚O acid 1770 cm-1, m C‚O ketone at
1693 cm1 and m C‚C at 1600 cm-1. The 1H NMR-
(DMSO-d6) was showed d 13.27 ppm (s, 1H, OH), and d
7.41–8.08 ppm (m, 13H, Ar-H); 13C NMR-(DMSO-d6)
showed d 196.09 ppm for C‚O ketone, d 166.95 ppm for
C‚O, acid and the mass spectra show 302 (M+): C20H14O3
(9.9%) (Scheme 1).
The cyclization reaction of 1 with hydrazine hydrate, phe-
nyl hydrazine, acetyl hydrazine and benzoyl hydrazine in boil-Scheme 1 (i): A1C13, dry C6H6 reﬂux; (ii): R-NHNH2, dry C6H6, reﬂ
6 h; (v): NH2OHÆHCl, EtOH, NaOH, reﬂux 6 h; (vi): NH2OHÆHCl, Py
EtOH; CH2O, Cone. HC1, reﬂux 16 h.ing dry benzene gave(Coates and Mckillop, 1993; Sayed et al.,
2003) the corresponding 4-biphenyl-4-yl-(2H)-phthalazin-1-
one (2a–d), respectively (Scheme 1).
The structure of 2a–d was conﬁrmed by elemental analysis
and IR, 1H NMR and mass spectra. The infrared spectrum of
2a showed the band tNH at 3421 cm-1 and disappearance of it
for 2b–d which prove the substitution in 2-position, also 1H
NMR spectrum showed the presence of a peak d 12.87 ppm
(1H, s, NH) and disappearance of this peak for 2b–d deriva-
tives. 13C NMR spectrum of 2a showed disappearance peak
of d C‚O acid, ketone and the presence of peak C‚O amide
in d159.21 ppm, d C‚N in d 146.02 ppm. On the other hand
structures of 2c,d were proved by reaction of 2a with a mixture
of acetic acid and acetic anhydride to give 2c and while, the
reaction of 2a with benzoyl chloride in pyridine gave 2d as
shown in Scheme 2.
The structure of 2c was further established via its reaction
with 2-chlorobenzaldehyde, 2- nitrobenzaldehyde in ethanol
to give the chalcon 3a,b, respectively, as shown in Scheme 1.
On the other hand the cyclocondensation reaction of ben-
zoic acid derivative 1 with semicarbazide and thiosemicarba-
zide in sodium acetate gave phthalazinone amide/thioamide
4a,b, respectively, as shown in Scheme 1. The infrared spectra
of 4a,b showed a peak NH2 at 3432, 3371 cm
1, respectively,
and disappearance peak of OH acid.ux 8 h; (iii): 2c, RCHO, RT; (iv): H2N(CX)NHNH2, EtOH, reﬂux
ridine, reﬂux l0 h; (vii): Ac2O, AcOH, reﬂux 4 h; (viii): 2a, Me2CO,
Scheme 2 (i):Ac20, AcOH, reﬂux 10 h; (ii): PhCOCl, Pyridine,
reﬂux 6 h.
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in different media was also studied when compound 1 was con-
densed with hydroxyl amine hydrochloride in boiling ethanol
to give oxime derivative 5 which was readily converted to ben-
zooxazin-1-one derivative 6 by boiling in acetic anhydride. On
the other hand compound 6 was also obtained when acid 1 was
reacted with hydroxyl amine hydrochloride in boiling pyridine.
The structures of compounds 5, 6 were conﬁrmed from spec-
tral data. The infrared spectrum for compound 5 showed a
peak of tOH at 3430.7 cm1, tCH-Ar at 3060–3029 cm1,
tC‚O acid at 1727 cm1 and t C‚N oxime at 1667 cm1.
It is interesting to investigate the behaviors of phthalazi-
none derivative 2a towards phthalimide, morpholine, o-cresole
and b-naphthol in the presence of formaldehyde, concentrated
hydrochloric acid and mixture of acetone and ethanol as a sol-
vent, under Mannich reaction condition (Demirbas et al., 2008
and Joshi et al., 2008) to afford Mannich bases 7a–d, respec-
tively. The structures of obtained compounds 7a–d were estab-
lished, the IR spectra showed disappearance of the peak NH
group in phthalazinone derivative 2a that prove the substitu-
tion in position-2 formed the Mannich bases.Table 1 Antibacterial activity of some phthalazine and phthalazino
Tested organism Bacillus subtilis
Concentration 1 2.5 5
Compound No. (mg/mL)
1 +++ +++ ++
2a   
2b  ++ ++
2c  +++ ++
2d ++ +++ ++
3a ++ ++++ ++
4a ++ +++ ++
4b +++ ++++ ++
6 ++++ ++++ ++
7a + ++ ++
() non inhibition zone; (+) diameter of inhibition zone up to 10 mm;
inhibition zone 16–22 mm; ++++: diameter of inhibition zone more t4. Biological screening
The activities of some of the new prepared compounds
phthalazine and phthalazinone against representative Gram
positive and negative bacteria were tested by the disk diffu-
sion method (El-Safty et al.,1991) biological activity of com-
pounds that have been prepared using the method of
deployment during agar (Cooper, 1972 and Wayne et al.,
1997) diffusion agar technique against species of Gram-posi-
tive bacteria such as Bacillus subtilis and Gram-negative bac-
teria such as Pseudomonas aeruginosa as well as some fungi
such as candida albicans and aspergillus niger, and use the
antibiotic chloramphenicol as a reference positive control to
compare the impact of fungi on the impact of derivatives
prepared, as used antibiotic anti-fungi grisoﬂavin reference
to compare the impact on the fungi and the impact of
derivatives prepared in a solvent N,N-dimethyl formamide
(DMF). Recorded the results of a survey of certain com-
pounds against the bacteria in the Table 1, and recorded
the results of a survey of certain compounds against fungi
in Table 2.
The results are listed in table 1, which shows that com-
pounds 2a have no activity against bacteria, Bacillus subtilis,
as demonstrated that the compound 2b have moderate activity
against the same type of bacteria, while compounds 1, 2c, 7a
showed a high activity against this type of bacteria, as while
as compounds 2d, 3a, 4a, 4b, 6 showed very high activity on
the same type of bacteria. The study found that compound
2c had no effect on the bacteria Pseudomonas aeruginosa,
where 2a, 2b, 6 showed high-activity against this type of bacte-
ria, while compounds 1, 3a, 4a, 4b, 7a have a very high activity
on the same type of bacteria.
The results are listed in table 2, which shows that com-
pounds 1, 2a, 2b, 6, 7a have no effect on fungus aspergillus ni-
ger, while the compounds 2c, 4b have an high impact on the
fungus Aspergillus niger, the compounds 2d, 3a also have a very
high impact on the fungus Aspergillus niger. The study found
that compounds 2b, 2c have an average impact on the fungus,
while the compounds 1, 2a, 2d, 4a, 4b have a strong biological
effect on the same type of fungus, as shown by compounds 3a,
6, 7a, which have very strong impact on the fungus Candida
albicans.ne derivatives.
Pseudomonas aeruginosa
1 2.5 5
(mg/mL)
+ ++++ ++++ ++++
+++ +++ +++
++ +++ +++
+   
++ ++++ ++++ ++++
++ ++++ ++++ ++++
++ ++++ ++++ ++++
++ ++++ ++++ ++++
++ ++ +++ +++
+ +++ +++ ++++
(++) diameter of inhibition zone 11–15 mm; (+++) diameter of
han 23 mm.
Table 2 Antifungal activity of some phthalazine and phthalazinone derivatives.
Tested organism Aspergillus niger Candida albicans
Concentration 1 2.5 5 1 2.5 5
Compound No. (mg/mL) (mg/mL)
1    ++ +++ +++
2a    ++ ++ +++
2b    ++ ++ ++
2c  ++ +++ ++ ++ ++
2d +++ +++ ++++ +++ +++ +++
3a ++++ ++++ ++++ ++++ ++++ ++++
4a ++ +++ +++ ++ +++ +++
4b  ++ +++ +++ +++ +++
6    ++ +++ ++++
7a    ++ ++ ++++
() Non inhibition zone; (+) diameter of inhibition zone up to 10 mm; (++) diameter of inhibition zone 11–15 mm; (+++) diameter of
inhibition zone 16–22 mm; (++++) diameter of inhibition zone more than 23 mm.
Synthesis and reactions of some novel 4-biphenyl-4-(2H)-phthalazin-1-one derivatives 655. Conclusions
In the present study acid 1 was reacted with hydrazine deriva-
tives in dry benzene to give the corresponding phthalazin-1-
ones 2a–d. The cyclocondensation took place by reactions of
acid 1 with semicarbazide and thiosemicarbazide in sodium
acetate to give phthalazinone amide derivatives. The reaction
of acid 1 with hydroxyl amine hydrochloride in different media
was also studied, to give oxime derivative which was readily
converted to benzooxazin-1-one derivative 6 by boiling in ace-
tic anhydride. Also under Mannich reaction condition the
phthalazinone derivative 2a reacted with phthalimide, mor-
pholine, o-crezole and b-naphthol to give Mannich bases 7a–
d, respectively. Additionally, the antimicrobial activity of se-
lected compounds against Gram positive and negative bacteria
and the antifungal activity are reported.Acknowledgement
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